Edwards Lifesciences Corp

EWNYSEUSD
81.51 USD
1.78 (2.23%)🟢PRE MARKET (AS OF 05:23 AM EDT)
🟢Market: OPEN
Open?$82.50
High?$82.50
Low?$81.50
Prev. Close?$79.72
Volume?3.4K
Avg. Volume?4.8M
VWAP?$81.53
Rel. Volume?0.00x
Bid / Ask
Bid?$81.50 × 2.9K
Ask?$83.39 × 100
Spread?$1.89
Midpoint?$82.45
Valuation & Ratios
Market Cap?46.0B
Shares Out?576.5M
Float?571.8M
Float %?99.2%
P/E Ratio?42.82
P/B Ratio?4.45
EPS?$1.86
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?3.72Strong
Quick Ratio?3.09Strong
Cash Ratio?1.62Strong
Debt/Equity?0.06Low
ValuationRICHLY VALUED
Score
44/100
P/E?
42.8PRICEY
P/B?
4.45FAIR
P/S?
7.57HIGH
P/FCF?
34.4FAIR
EV/EBITDA?
24.8HIGH
EV/Sales?
7.19HIGH
Returns & Efficiency
ROE?
10.4%FAIR
ROA?
7.8%STRONG
Cash Flow & Enterprise
FCF?$1.3B
Enterprise Value?$43.6B
News
Profile
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.
Employees
16.0K
Market Cap
46.0B
Industry
ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
Listed
2000-04-03
Address
ONE EDWARDS WAY
IRVINE, CA 92614
Phone: (949) 250-2500